T-LGLL patient serum has significantly elevated IFN-γ compared to healthy controls [22] and T-LGLL patient peripheral blood mononuclear cells (PBMCs) exhibit constitutively activated STAT1 [23], suggesting hyperactivation of the IFN-γ signaling pathway. The gene discussed is STAT1; the disease is T-cell large granular lymphocyte leukemia.